News & Analysis on Clinical Trial Services & Contract Research And Development
GlaxoSmithKline has halted clinical trials of its first-in-class HIV drug after cases of hepatotoxicity was discovered in treatment-naïve patients. The setback does not mean the end of development for this drug candidate but suggests Glaxo has lost...
KemFine, the fine chemicals business created via a management buyout from chemicals group Kemira last year, has acquired Avecia Fine Chemicals' business based in Grangemouth, Scotland.
A new drug candidate, which targets the protein that protects cancer cells from dying, has been shown to exhibit increased anti-tumour activity when combined with an existing cancer treatments. The data gives hope to those who have acquired drug...
Germany's Merck KGaA has laid out its plans to take on the market for generic respiratory medicines, revealing that it is the previously unnamed company that has licensed UK inhaler company Innovata's Clickhaler device in European markets.
Researchers in the US have constructed a new virus-based gene therapy delivery system that has uses in cancer treatment. The findings are said to provide a solution to the problems that have hampered gene therapy treatments.
Italy's Bonfiglioli has updated its BLI leak testing machine for blister packaging, first introduced last year, with the ability to automate sampling between the blister machine and the cartoner for in-process automatic testing.
Nabi Pharmaceuticals has received a $4.1 million grant to advance the only vaccine being developed in the US and Europe for tobacco addiction. The vaccine is being developed to treat nicotine addiction and smoking relapse with a view to reducing the 5...
A discovery by scientists may provide a novel method to generate proteins, providing an effective way of generating therapeutic enzymes and other medically important proteins to produce novel drugs.